Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenwei Ningyu Pian for Depression (Qi and Yin Deficiency) Phase III Trial
CTR20171668Phase 3Completed
- Sponsor
- Guangdong Laida Pharmaceutical
- Start
- Mar 2018
- Countries
- 1
01
Overview
A Phase 3 trial of Shenwei Ningyu in major depressive disorder (MDD), sponsored by Guangdong Laida Pharmaceutical. Started Mar 2018; status: completed.
02
Drugs
Shenwei Ningyu
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20171668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171668.